Riskpilot← Back to searchSign inGet full accessMega Care, Gardulf AB
ABActiveOrg 5568701410Timmermansgatan 39General medical practice activities · NACE 8621Est. 20110 employees
Revenue 2025
SEK 2K
0% vs 2024
EBITDA margin
-7800.0%
+17% vs 2024
Equity ratio
43.2%
Financial strength
Net profit 2025
SEK 19K
-67% vs 2024
| Revenue | SEK 2K | +0% |
| EBITDA | SEK -156K | +17% |
| Net profit | SEK 19K | -67% |
| Total assets | SEK 1,9M | -6% |
| Equity | SEK 804K | -19% |
| Employees | 0 | — |
Legal name
Mega Care, Gardulf AB
Org number
5568701410
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 november 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva hälso och sjukvård samt forskning, utveckling och utbildning inom hälso- och sjukvård och därmed förenlig verksamhet.
Address
Timmermansgatan 39
Phone
+46705856696
Email
ann.gardulf@megacare.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 411 | 660 | 140 | 2 | 2 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 051 | 490 | −51 | −189 | −156 |
| Depreciation & amort. | −26 | −26 | −26 | −0 | −0 |
| EBIT | 1 025 | 464 | −77 | −189 | −156 |
| Net financials | −6 | — | 3 | 39 | 20 |
| Profit before tax | 818 | 450 | 29 | 85 | 32 |
| Tax | −178 | −94 | −9 | −27 | −13 |
| Net profit | 640 | 356 | 20 | 58 | 19 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 489 | 2 814 | 2 340 | 1 982 | 1 863 |
| Equity | 1 122 | 1 294 | 1 126 | 989 | 804 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 343 | 482 | 278 | 292 | 527 |
| Total debt | 343 | 482 | 278 | 292 | 527 |
EBITDA margin
-7800.0%
This company
15.8%
Market median
-49467% vs market
20212025
Equity ratio
43.2%
This company
38.2%
Market median
+13% vs market
20212025
Return on equity
2.4%
This company
18.4%
Market median
-87% vs market
20212025
Net profit margin
950.0%
This company
8.1%
Market median
+11628% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
ME Audit | Audit | 2022 – 2023 |
AM Chief Auditor | Chief Auditor | 2022 – 2022 |
SK Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mega Care, Gardulf AB 
Vaccinum ABBoard members of Mega Care, Gardulf AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Eva Bengtsson | Audit | 0 companies |
| Anna M E Lundeborn Bengtsson | Chief Auditor | 0 companies |
| Siv Katrine Elbra | Audit | 0 companies |
| Kennet Tommy Oxelgren | Deputy Board Member | 0 companies |
| Ann Elisabeth Maria Gardulf | Board of Directors | 0 companies |